Starna announce accreditation to the new Reference Material Producer (RMP) ISO 17034 Accreditation for its Certified Reference Materials (CRMs) for Photometry IPV.
Starna is perfectly placed to support laboratories accredited to the new ISO/IEC 17025:2017, where for the first time there are clear and unambiguous statements in the standard that ‘Certified values of certified reference materials from RMPs conforming to ISO 17034 provide metrological traceability’, and ‘RMPs fulfilling the requirements of ISO 17034 are considered to be competent’.
The new ISO 17034 outlines the general requirements for the producers of Reference Materials, including CRMs and is therefore an essential consideration when selecting an appropriate Reference Material Producers (RMPs) to supply your CRMs.
Starna Scientific Ltd. was the first laboratory to be accredited to ISO Guide 34 by UKAS, No. ‘4001’ in 2006. We are now pleased to announce that we have been successfully assessed according to the requirements of the recently published ISO 17034:2016 Standard.
CRMs from Starna cover the spectrum from the Deep UV to the Mid IR for wavelength accuracy, absorbance/photometric linearity, stray light and instrument resolution. They also offer a wide selection of fluorescent references, and other formats such as plate readers and point of care devices are covered.
Starna – Supporting your data integrity through fully compliant Instrument Performance Qualification CRMs
Company name: Starna Scientific Ltd.
Website: www.starna.com
E-mail: sales@starna.com
Drug Solutions Podcast: Novel Drug Delivery Approaches: Refining AAV Vector Deliveries
May 30th 2025In this podcast episode, we discuss novel approaches to drug delivery, specifically regarding adeno-associated virus (AAV) vectors, as viewed by two industry experts who recently exhibited at the annual ASGCT meeting.
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
A Novel, Enhanced, and Sustainable Approach to Audit Trail Review
July 4th 2025Eli Lilly and Company developed an innovative and sustainable approach to audit trail review (ATR) aimed at reducing the ATR burden while adhering to regulatory expectations and data integrity (DI) principles. The process has transformed employees' understanding of ATR and complemented the DI by design approach, leading to better system designs that meet expected controls and reduce non-value-added data reviews.